C. Auclair

1.1k total citations
16 papers, 851 citations indexed

About

C. Auclair is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Biochemistry. According to data from OpenAlex, C. Auclair has authored 16 papers receiving a total of 851 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Biochemistry. Recurrent topics in C. Auclair's work include Amino Acid Enzymes and Metabolism (6 papers), Sexual Differentiation and Disorders (5 papers) and Hormonal and reproductive studies (4 papers). C. Auclair is often cited by papers focused on Amino Acid Enzymes and Metabolism (6 papers), Sexual Differentiation and Disorders (5 papers) and Hormonal and reproductive studies (4 papers). C. Auclair collaborates with scholars based in Canada and United States. C. Auclair's co-authors include Fernand Labrie, Paul A. Kelly, L. Cusan, Andrew V. Schally, Louise Ferland, Carl Séguin, A. Bèlanger, David H. Coy, G. S. Kledzik and D. H. Coy and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Endocrinology and Fertility and Sterility.

In The Last Decade

C. Auclair

16 papers receiving 768 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C. Auclair Canada	11	491	464	214	128	105	16	851
J. Sandow Germany	16	367 0.7×	441 1.0×	226 1.1×	115 0.9×	247 2.4×	52	978
R. A. SHAKESPEAR United Kingdom	15	462 0.9×	263 0.6×	125 0.6×	92 0.7×	20 0.2×	16	753
S.B. Cigorraga Argentina	13	346 0.7×	462 1.0×	274 1.3×	171 1.3×	15 0.1×	19	874
William S. McLean United States	11	366 0.7×	348 0.8×	213 1.0×	111 0.9×	35 0.3×	14	587
K Nozu United States	11	416 0.8×	420 0.9×	231 1.1×	215 1.7×	14 0.1×	13	821
M L Dufau United States	7	217 0.4×	288 0.6×	216 1.0×	161 1.3×	14 0.1×	9	654
Shoichi Okinaga Japan	14	137 0.3×	232 0.5×	206 1.0×	159 1.2×	38 0.4×	54	633
Mohan Katikineni United States	10	308 0.6×	421 0.9×	148 0.7×	126 1.0×	14 0.1×	10	670
S.C. Weddington Sweden	15	588 1.2×	558 1.2×	338 1.6×	139 1.1×	63 0.6×	21	921
John L. Fakunding United States	14	312 0.6×	234 0.5×	632 3.0×	177 1.4×	37 0.4×	19	1.0k

Countries citing papers authored by C. Auclair

Since Specialization

Citations

This map shows the geographic impact of C. Auclair's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Auclair with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Auclair more than expected).

Fields of papers citing papers by C. Auclair

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Auclair. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Auclair. The network helps show where C. Auclair may publish in the future.

Co-authorship network of co-authors of C. Auclair

This figure shows the co-authorship network connecting the top 25 collaborators of C. Auclair. A scholar is included among the top collaborators of C. Auclair based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Auclair. C. Auclair is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Montaner, Julio, Anita Rachlis, R Beaulieu, et al.. (1994). Safety profile of didanosine among patients with advanced HIV disease who are intolerant to or deteriorate despite zidovudine therapy: results of the Canadian Open ddI Treatment Program.. PubMed. 7(9). 924–30. 6 indexed citations

Auclair, C. & Morris L. Givner. (1982). Medrogestone and an LHRH Analogue as Potential Combination Therapy for Hormone-Dependent Cancers. Archives of Andrology. 8(1). 21–24. 3 indexed citations

Auclair, C., Mariana C. Stern, & Morris L. Givner. (1981). LHRH and Analogues as Potential Therapy for Benign Prostatic Hyperplasia and Hormone-Dependent Cancers. Archives of Andrology. 7(3). 237–244. 7 indexed citations

Bélanger, Alain, C. Auclair, Carl Séguin, S. Caron, & Fernand Labrie. (1981). Prolactin Stimulation of Testicular Steroid Biosynthesis in the Male Rat. Journal of Andrology. 2(2). 80–86. 10 indexed citations

Bèlanger, A., L. Cusan, C. Auclair, et al.. (1980). Effect of an LHRH Agonist and hCG on Testicular Steroidogenesis in the Adult Rat. Biology of Reproduction. 22(5). 1094–1101. 32 indexed citations

Bèlanger, A., C. Auclair, Louise Ferland, S. Caron, & Fernand Labrie. (1980). Time-course of the effect of treatment with a potent LHRH agonist on testicular steroidogenesis and gonadotropin receptor levels in the adult rat. Journal of Steroid Biochemistry. 13(2). 191–196. 50 indexed citations

Cusan, L., C. Auclair, Alain Bélanger, et al.. (1979). Inhibitory Effects of Long Term Treatment with a Luteinizing Hormone-Releasing Hormone Agonist on the Pituitary-Gonadal Axis in Male and Female Rats. Endocrinology. 104(5). 1369–1376. 111 indexed citations

Labrie, Fernand, C. Auclair, L. Cusan, et al.. (1979). Inhibitory Effects of Treatment with LHRH or Its Agonists on Ovarian Receptor Levels and Function. Advances in experimental medicine and biology. 112. 687–693. 16 indexed citations

Bèlanger, A., C. Auclair, Carl Séguin, Paul A. Kelly, & Fernand Labrie. (1979). Down-regulation of testicular androgen biosynthesis and LH receptor levels by an LHRH agonist: role of prolactin. Molecular and Cellular Endocrinology. 13(1). 47–53. 71 indexed citations

10.

Kledzik, G. S., L. Cusan, C. Auclair, Paul A. Kelly, & Fernand Labrie. (1978). Inhibitory Effect of a Luteinizing Hormone (LH)-Releasing Hormone Agonist on Rat Ovarian LH and Follicle-Stimulating Hormone Receptor Levels During Pregnancy. Fertility and Sterility. 29(5). 560–564. 65 indexed citations

11.

Kledzik, G. S., L. Cusan, C. Auclair, Paul A. Kelly, & Fernand Labrie. (1978). Inhibition of Ovarian Luteinizing Hormone (LH) and Follicle-Stimulating Hormone Receptor Levels With an LH-Releasing Hormone Agonist During the Estrous Cycle in the Rat. Fertility and Sterility. 30(3). 348–353. 49 indexed citations

12.

Auclair, C., Louise Ferland, L. Cusan, et al.. (1978). [Inhibitory effects of LHRH on LH receptors in the rat testis].. PubMed. 286(18). 1305–7. 1 indexed citations

13.

Pelletier, G., et al.. (1978). INHIBITION OF SPERMATOGENESIS IN THE RAT BY TREATMENT WITH [D-Ala⁶,DES-GLY-NH₂¹⁰]LHRH ETHYLAMIDE. Endocrinology. 103(2). 641–643. 76 indexed citations

14.

Labrie, Fernand, C. Auclair, L. Cusan, et al.. (1978). Inhibitory Effect of LHRH and Its Agonists on Testicular Gonadotrophin Receptors and Spermatogenesis in the Rat. International Journal of Andrology. 1(s2a). 303–318. 99 indexed citations

15.

Auclair, C., Paul A. Kelly, Fernand Labrie, David H. Coy, & Andrew V. Schally. (1977). Inhibition of testicular luteinizing hormone receptor level by treatment with a potent luteinizing hormone-releasing hormone agonist or human chorionic gonadotropin. Biochemical and Biophysical Research Communications. 76(3). 855–862. 143 indexed citations

16.

Auclair, C., Paul A. Kelly, D. H. Coy, Andrew V. Schally, & Fernand Labrie. (1977). POTENT INHIBITORY ACTIVITY OF [D-LEU⁶, DES-GLY-NH₂1Q]LHRH ETHYLAMIDE ON LH/hCG AND PRL TESTICULAR RECEPTOR LEVELS IN THE RAT. Endocrinology. 101(6). 1890–1893. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact